Inuacare ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.1% 5.5% 5.0% 3.3% 2.8%  
Credit score (0-100)  45 41 42 55 59  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  227 155 173 264 785  
EBITDA  97.7 40.4 91.1 107 435  
EBIT  97.7 30.4 61.1 77.4 365  
Pre-tax profit (PTP)  74.8 12.3 42.5 65.8 357.9  
Net earnings  62.3 1.7 31.2 45.2 263.0  
Pre-tax profit without non-rec. items  74.8 12.3 42.5 65.8 358  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  265 255 145 135 85.0  
Shareholders equity total  112 114 145 191 454  
Interest-bearing liabilities  375 311 311 357 63.0  
Balance sheet total (assets)  549 494 822 612 739  

Net Debt  373 311 309 353 -353  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  227 155 173 264 785  
Gross profit growth  0.0% -31.7% 11.7% 52.6% 197.5%  
Employees  0 0 0 0 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  -128.9 -114.4 -81.8 -156.4 -350.0  
Balance sheet total (assets)  549 494 822 612 739  
Balance sheet change%  0.0% -9.9% 66.2% -25.5% 20.7%  
Added value  226.6 154.8 172.9 263.8 784.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  265 -20 -60 -60 -140  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  43.1% 19.6% 35.3% 29.3% 46.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  17.8% 5.8% 9.3% 11.1% 54.0%  
ROI %  19.6% 6.4% 13.1% 15.0% 65.6%  
ROE %  55.4% 1.5% 24.1% 26.9% 81.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  20.5% 23.1% 17.7% 31.1% 61.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  381.5% 769.4% 339.7% 328.8% -81.3%  
Gearing %  333.6% 272.9% 214.2% 187.2% 13.9%  
Net interest  0 0 0 0 0  
Financing costs %  12.2% 5.3% 6.0% 4.2% 3.3%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.1 0.0 0.4 0.2 1.7  
Current Ratio  0.7 0.7 0.9 1.1 2.3  
Cash and cash equivalent  2.0 0.5 2.0 3.5 416.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -140.1 -117.8 -51.2 25.4 346.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 392  
Employee expenses / employee  0 0 0 0 -175  
EBITDA / employee  0 0 0 0 217  
EBIT / employee  0 0 0 0 182  
Net earnings / employee  0 0 0 0 132